Lung Cancer Clinical Trial

Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)

Summary

Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Is eligible for LDCT for LCS follow-up
Has technology to complete study activities (e.g., video call visit)
English speaker
Has undergone LCS at UMMH
Is overdue for LDCT follow-up

Exclusion Criteria:

Has previous diagnosis of lung cancer
Has active cancer diagnosis
Is a nursing home or group care resident
Is pregnant

Study is for people with:

Lung Cancer

Estimated Enrollment:

22

Study ID:

NCT05021133

Recruitment Status:

Active, not recruiting

Sponsor:

University of Massachusetts, Worcester

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UMass Chan Medical School
Worcester Massachusetts, 01655, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

22

Study ID:

NCT05021133

Recruitment Status:

Active, not recruiting

Sponsor:


University of Massachusetts, Worcester

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.